Used in the synthesis of glycopeptide-based vaccines and immunotherapeutics, particularly targeting carbohydrate-binding proteins involved in immune recognition. The tetra-O-acetylated trisaccharide moiety mimics natural oligomannose structures found on pathogenic glycoproteins, enabling controlled study of antibody responses and dendritic cell targeting. Commonly employed in solid-phase peptide synthesis to incorporate well-defined mannosylated epitopes into larger peptide constructs for vaccine development against HIV, cancer, and fungal infections. The Fmoc group allows for stepwise assembly using standard peptide coupling techniques, while the acetyl groups protect hydroxyl functionalities during synthesis and can be removed post-assembly to reveal free hydroxyls for further conjugation or biological evaluation.